Pascal Biosciences is dedicated to improving the lives of patients suffering from life-threatening diseases including COVID-19 and intractable cancers such as glioblastoma. We are developing novel cannabinoid-based small molecules and targeted antibodies, focusing on treatments for SAR-CoV-2 infection and cancers for which there are no adequate therapies.
September 16, 2020Read More
Pascal Biosciences and SōRSE Technology Announce Partnership for Cannabinoid Drug Development and Cancer Clinical Trials
September 14, 2020Read More